Every patient’s journey with chronic disease is unique, requiring customized treatment approaches that address their specific medical needs. Our exceptional team of specialized scientists combines innovative research with advanced technology to develop targeted therapies that deliver superior patient outcomes and improved quality of life.
Individualized therapeutic solutions offer remarkable opportunities to address previously challenging medical conditions. Our dedicated team of expert researchers is actively converting this tremendous potential into real-world results, creating specialized autologous treatments specifically designed to effectively combat various chronic diseases, including complex cancer cases.
Q-REstrain
Q-REstrain uses advanced microRNA technology to target and regulate specific genes involved in disease progression. This innovative therapy works by using small RNA molecules that can silence overactive genes, particularly those contributing to cancer growth. The treatment is personalized using the patient’s own cellular material, making it highly targeted and effective. Q-REstrain has shown promising results in treating various cancers, viral infections, and respiratory diseases by precisely controlling gene expression at the cellular level.
Clavic-Q-RE
Clavic-Q-RE is a personalized immune cell therapy that strengthens the body’s natural ability to fight cancer. This treatment uses the patient’s own immune cells, including natural killer cells and specialized lymphocytes, which are enhanced and activated in our laboratory. These boosted cells are then reintroduced to the patient to create a powerful anti-tumor response. The therapy is completely personalized, using only the patient’s own cells, making it a safe and targeted approach to cancer treatment.
Vaccine Prep (ATA)
Vaccine Prep (ATA) is an innovative immunotherapy that trains the patient’s immune system to recognize and destroy cancer cells more effectively. This treatment uses components from the patient’s own tumor cells to create a personalized vaccine. The therapy helps the immune system identify cancer-specific markers, enabling it to mount a stronger, more targeted response against the disease. This personalized approach has shown excellent results with minimal side effects.
Dendritic Cell Therapy
Dendritic Cell Therapy activates the body’s most powerful immune cells to fight cancer more effectively. Dendritic cells act as the immune system’s messengers, teaching other immune cells how to recognize and attack cancer. In this treatment, the patient’s dendritic cells are collected, activated with cancer-specific information in our laboratory, and then returned to the patient. This enhanced immune response provides better tumor recognition and improved treatment outcomes with reduced side effects.
- Faq’s
Answers to Your Most Frequently Asked Questions
Unlike chemotherapy or radiation, our therapies use your own immune cells and genetic material to fight disease naturally. This personalized approach targets cancer more precisely while minimizing side effects on healthy cells.
The complete process typically takes 4-6 weeks. This includes collecting your samples, processing them in our laboratory to create your personalized treatment, and administering the therapy back to you.
Yes, these therapies are generally very safe because they use your own cells and natural immune system. Side effects are typically mild and may include temporary fatigue or minor flu-like symptoms as your immune system becomes more active.